Discovery of novel inhibitor of 11 beta-hydroxysteroid dehydrogenase type 1 using in silico structure-based screening approach for the treatment of type 2 diabetes
Crossref DOI link: https://doi.org/10.1007/s40200-023-01191-8
Published Online: 2023-03-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Devang, Nayana http://orcid.org/0000-0001-9952-5664
Banjan, Bhavya
V.K., Priya
Text and Data Mining valid from 2023-03-06
Version of Record valid from 2023-03-06
Article History
Received: 10 September 2022
Accepted: 23 January 2023
First Online: 6 March 2023
Declarations
:
: Authors declare there is no conflict of interest.